Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study. [electronic resource]
Producer: 20070517Description: 415-27 p. digitalISSN:- 0002-953X
- Adult
- Antipsychotic Agents -- adverse effects
- Benzodiazepines -- adverse effects
- Chronic Disease
- Dibenzothiazepines -- adverse effects
- Double-Blind Method
- Drug Administration Schedule
- Female
- Humans
- Male
- Olanzapine
- Patient Dropouts
- Perphenazine -- administration & dosage
- Proportional Hazards Models
- Psychiatric Status Rating Scales
- Quetiapine Fumarate
- Risperidone -- adverse effects
- Schizophrenia -- diagnosis
- Schizophrenic Psychology
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.